MEDBRIGHT AI INVTS INC - MBAIF STOCK NEWS

MedBright AI Investments Inc. has achieved its near term goal of total clinic revenue under management with MedMatrix, an AI-powered data analytics platform. 14 clinics in the US and Canada, representing an estimated US$100M in total clinic revenue, are now using MedMatrix. The adoption has been extraordinary, with multiple clinic groups signing on in just two short months. MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of healthcare facilities, resulting in more efficient clinic operations and improved patient outcomes.

MedBright AI Investments Inc. has been requested by OTC Markets Group Inc. to issue a statement.

MedBright AI Investments Inc. (MBAI) is pleased to announce that Rejuvenation medical group, a prominent dermatology group in Canada, has decided to adopt MedMatrix, an AI-powered data analytics platform, across all its 9 clinics. Rejuvenation medical group caters to over 750,000 patients each year and has a highly skilled team comprising 21 dermatologists, 5 Mohs surgeons, 2 plastic surgeons, and 13 general practitioners. MedMatrix aims to enhance their already formidable healthcare offerings through advanced AI and data analytics capabilities.

MedBright AI Investments Inc. (MBAI) announces the appointment of Trevor Vieweg as CEO and an investor relations agreement with Outside the Box Capital Inc. The new CEO brings extensive AI and commercial expertise from his previous roles. The company aims to monetize AI investment opportunities in the healthcare sector. The investor relations agreement includes social media engagement services and the grant of 400,000 incentive stock options.

MedBright AI Investments Inc. (MBAI) announces the issuance of 350 common shares of MB Acquisition Co. to Limmi pursuant to an intellectual property license and option agreement. Limmi granted certain rights to the Limmi AI Platform in exchange for the MBAC Shares, subject to specific conditions and an option for MB Licensing Co. to purchase the platform. MedBright also created a new class of non-voting common shares, the MedBright Class A Shares, and agreed to pay an arm's length finder 1,000,000 Common Shares.

MedBright AI Investments Inc. (MBAI) announced that CareMEDICA, a leading clinic group in Connecticut and South Florida, has chosen to implement the beta version of MedMatrix, an AI-powered data analytics platform, into its practice. CareMEDICA, affiliated with Yale University School of Medicine and Quinnipiac University Medical Program, aims to optimize clinic operations and improve patient outcomes through the use of AI technology.

MedBright AI Investments Inc. (MBAI) has been making significant moves, including a name change to MedBright, supporting medical economics lectures at Yale University School of Medicine, appointing highly qualified board members, and launching MedMatrix, an AI-powered data analytics platform. The company seems focused on acquiring customers and maintaining transparency, signaling a positive business outlook.

MedBright AI Investments Inc. (MBAI) is pleased to announce that the Dermatology Institute & Skin Care Center (DISCC) in Southern California has chosen to implement MedMatrix, an AI-powered data analytics platform developed by Healthcare Accretion AI, to improve their clinic operations.

MedBright AI Investments Inc. (MBAI) welcomes Dr. Jaime Gerber and Dr. Konita Wilks as new board members. Dr. Gerber, a cardiologist and Professor of Medicine at Yale, will serve as Chairman of the Board. Dr. Wilks, a CEO with over 25 years of experience in healthcare and the military, brings valuable expertise. The shareholders have also approved the creation of a new class of Class 'A' non-voting common shares in connection with the Company’s transaction with an FDA & HIPPA compliant Artificial Intelligence Platform 'AIP' doing business as Limmi, a Delaware corporation named Mentorhead Incorporated.